June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Morphological and functional outcomes of different pattern of diabetic macular oedema treated with 23gauge vitrectomy
Author Affiliations & Notes
  • Giancarlo Sborgia
    Medical Retina, Miulli, Acquaviva delle Fonti, Italy
  • Luisa Micelli Ferrari
    Azienda Ospedaliera Policlinico Consorziale, Bari, Italy
  • Massimo Lorusso
    Medical Retina, Miulli, Acquaviva delle Fonti, Italy
  • Saba Ciani
    Medical Retina, Miulli, Acquaviva delle Fonti, Italy
    Azienda Ospedaliera Policlinico Consorziale, Bari, Italy
  • Marco Leozappa
    Medical Retina, Miulli, Acquaviva delle Fonti, Italy
  • Tommaso Micelli Ferrari
    Medical Retina, Miulli, Acquaviva delle Fonti, Italy
  • Footnotes
    Commercial Relationships Giancarlo Sborgia, None; Luisa Micelli Ferrari, None; Massimo Lorusso, None; Saba Ciani, None; Marco Leozappa, None; Tommaso Micelli Ferrari, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2441. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Giancarlo Sborgia, Luisa Micelli Ferrari, Massimo Lorusso, Saba Ciani, Marco Leozappa, Tommaso Micelli Ferrari; Morphological and functional outcomes of different pattern of diabetic macular oedema treated with 23gauge vitrectomy. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2441.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evacuate predictivity factor of OCT pattern in diabetic patient undergone to vitrectomy and peeling ILM.

Methods: 28 eyes, 18 men and 10 woman, aged between 52 e 65 years old, underwent surgery between january and july 2012. Participants were split into three groups: 1. sponge-like diffuse retinal thickening (10 eyes), 2. cystoid macular edema (8 eyes) and 3. diffuse retinal thickening with cysts (10 eyes). We performed in each patient BCVA the day before and one month after surgery, OCT ZEISS CIRRUS (Macular Cube 512x128) the day before and one month after surgery and vitrectomy 23G and peeling ILM after staining with indocyanine green. we evaluated the BCVA, the central macular thickness (CMT) and the maximum macular thickeness (MMT) in each group. The mean of BCVA logMAR was 0,48 in group1, 0,76 in group 2, 0, in group 3. The mean of the CMT was 455,3 micron in group 1, 527,12 micron in group 2, 550,9 micron in group 3. The mean of the MMT was 506,5 micron in group 1, 582,87 micron in group 2, 594,4 micron in group 3. Then we divided the patients into two groups: A) macular edema with savings the retinal outer layers (9 eyes) B) macular edema without saving the outer retinal layers (19 eyes). In group A , before surgery, the mean of the CMT was 404,67 micron; the mean of the MMT was 468 micron; the mean of BCVA was 0,55. In group B , before surgery, the mean of the CMT was 559,84 micron; the mean of the MMT was 604,42 micron; the mean of BCVA was 0,85

Results: After one months the mean of BCVA was 0,37 in group1, 0,53 in group 2, 0,54 in group 3. The mean of the CMT was 281 micron in group 1, 297 micron in group 2, 296,5 micron in group 3. the mean of the MMT was 401,9 micron in group 1, 391 micron in group 2, 406,2 micron in group 3. In group A after surgery the mean of the CMT was 301,55 micron; the mean of the MMT was 372,89 micron; the mean of BCVA was 0,3.In group B after surgery the mean of the CMT was 286,16 micron; the mean of the MMT was 399,47 micron; the mean of BCVA was 0,59.

Conclusions: There isn’t a correlation between morphological OCT edema pattern and anatomical results therefore the study suggests that the integrity of the outer retinal layers (ELM and photoreceptors) as well as a better pre-operative BCVA represent a positive prognostic factor for functional outcomes.

Keywords: 499 diabetic retinopathy • 505 edema • 762 vitreoretinal surgery  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×